MANKIND PHARMA Q4 CONCALL HIGHLIGHTS

Edit this post
MANKIND PHARMA Q4 CONCALL HIGHLIGHTS

■ Consumer Healthcare (OTC):

FY25 Revenue: ₹890 Cr (+15%)

Modern trade & e-comm: +77%

EBITDA margin in high teens; ~7% of total sales

■ BSV Acquisition:

Strengthened presence in gynecology; IPM share now 4.8% (value), 6% (volume)

Integration costs: ₹25 Cr in Q4

Targeting 18–20% growth for BSV; >20% for international

Synergies of ₹50–100 Cr expected in 12–24 months

Join👇👇

@Stock_aaj_or_kal

Related Posts

Nifty / Bank Nifty Option Tip

Looking to trade intraday Nifty or Bank Nifty options? Our Nifty / Bank Nifty Option Tip shares trading calls with a defined entry, target and stop loss, so you know your risk before you trade. It suits traders who follow the market on a trading screen as well as those who place orders through their broker or by phone. Click on Image or Post Title to Read More.

Latest Video Reviews by Clients

Watch video reviews recorded by our clients about their experience with Indian-Share-Tips.com services, including the Nifty / Bank Nifty Option Tip and Delivery Tip. Click on Image or Post Title to Read More.

Awards and Recognition

See the awards and recognition Indian-Share-Tips.com has received over the years for its work in stock market research and investor education. Click on Image or Post Title to Read More.